Developmental stability reflects the ability of a genotype to
undergo stable development of
a phenotype under given environmental conditions. Deviations from
developmental stability
arise from the disruptive effects of a wide range of environmental and
genetic stresses, and
such deviations are usually measured in terms of fluctuating
asymmetry and phenodeviants.
Fluctuating asymmetry is the most sensitive indicator of the ability to
cope with stresses
during ontogeny. There is considerable evidence that developmental
stability, and especially
fluctuating asymmetry, is a useful measure of phenotypic and genetic
quality, because it
covaries negatively with performance in multiple fitness domains in
many species, including
humans. It is proposed that developmental stability is an important marker
of
human health.
Our goal is to initiate formally the integration of the sciences of
evolutionary biology,
developmental biology and medicine. We believe that this integrative framework
provides a
significant addition to the growing field of Darwinian medicine. The
literature linking
developmental stability and disease in humans is reviewed. Recent biological
theoretical
treatments pertaining to developmental stability are applied to a range
of
human health issues
such as genetic diseases, ageing and survival, subfertility, abortion,
child maltreatment by
parents, cancer, infectious diseases, physiological and mental health,
and
physical attractiveness as a health certification.